Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03154684
Other study ID # 2016-01820
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date May 5, 2017
Est. completion date August 15, 2021

Study information

Verified date August 2021
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to test if the STARK comprehensive autonomy health care package improves lower extremity function over time at 6 weeks, 3, 6 and 12 months after hip or pelvis fracture compared to the standard of care.


Description:

Hip fractures are the most frequent and most severe fractures among seniors age 75 and older and they have severe consequences: After a hip fracture, 50% of older persons have permanent functional disabilities, 15-30% require long-term nursing home care, and 10-20% die within one year. Besides the personal burden, hip fractures account for substantial increasing health care expenses. Given the high prevalence, severity and cost of hip fractures, novel care concepts such as STARK are urgently needed to support functionality and autonomy of hip fracture patients - especially in for the first year after the fracture The STARK Intervention is a new care concept for hip fracture patients, which was developed based on prior evidence from clinical trials performed at the Centre on Aging and Mobility at the University of Zurich and important interdisciplinary clinical expertise collected at the Geriatric Trauma Centre at the University Hospital Zurich, the Spitex Zürich, the Dept. of Geriatrics at the University Hospital Zurich, and the Federal Department of Health at the City of Zurich (Gesundheits- und Umweltsdepartement). The aim of the STARK intervention is to enable hip fracture patient to return to their home directly after discharge from acute care by providing a high-quality care concept provided by an interdisciplinary team bridging acute Geriatric Care at the University Hospital and Spitex services (ambulant nursing service at home). With this pilot study, the investigators want to test if the STARK comprehensive autonomy care package improves lower extremity function in the first year after a hip fracture compared to standard of care. Most important secondary outcomes are rate of falls, health care utilization, re-hospitalization and nursing home admission, as well as quality of life, cognitive function, bone mineral density and muscle mass in senior hip fracture patients. This study will include 20 community-dwelling men and women aged 70+ who are hospitalized at the University Hospital Zurich or City Hospital Waid due to an acute hip or pelvis fracture and who are not capable to return home without help. This is a randomized controlled pilot trial with two parallel groups including a control group receiving standard of care (inpatient rehabilitation or home-based or inpatient transitional nursing care) and an intervention group receiving the STARK comprehensive autonomy health care package. The STARK comprehensive autonomy health care package consists on one hand of the STARK-Spitex who will support the participants during the first three months at home and on the other hand of a secondary prevention program including home exercise (3x/week), protein enriched food preparation (20 g whey protein/day), motivation and recommendation for vitamin D supplementation(2000 IE/day), calcium intake and physical activity. The intervention starts already during acute care and involves a multidisciplinary team of geriatricians, nurses and Spitex who assess the care and utilities needs of the patient. Each study participant will undergo 5 clinical visits (at baseline, after 6 weeks, 3 months, 6 months, and 12 months). Between clinical visits, participants will be contacted by phone every month. The STARK comprehensive autonomy health care package can contribute to a faster and sustainable recovery of autonomy after a hip fracture in seniors and might help to lower direct and indirect health care costs by reducing the number of re-hospitalization due to fall-associated injuries.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date August 15, 2021
Est. primary completion date August 15, 2021
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - Community-dwelling prior to the hip fracture event - Living alone or with a partner/family member - Living in the city of Zurich - age 70+ - Acute hip or pelvis fracture after minimal trauma (resulting from a fall occurring from a standard height and without the involvement of others or a vehicle) - Living at home without or with minimal (i.e. no more than 1x/day) support from the Spitex (ambulant nursing service) before the hip fracture - Participant is mentally competent (judicious) based on the treating physicians' opinion at the screening visit. - Inpatient rehabilitation or inpatient transitional care at a nursing home or ambulatory standard of care - The participant understands the study procedures and voluntarily agree to participate in the study and comply with all its procedures by giving written informed consent Exclusion Criteria: - Patients who are expected to return home without help (i.e. no more care than Spitex 1x/day or physiotherapy 2x/week needed) directly after acute care are excluded. - Conservative treatment of acute hip fracture or surgical treatment that does not allow full weight bearing after surgery - Currently under cancer treatment or has active cancer (except for non-melanoma skin cancer) - Major visual or hearing impairment (visual and/or hearing aids are allowed) or other serious illness that would preclude participation - 24-hour nursing care need as this cannot be offered within the STARK package - Mobility impairment that precludes return to own apartment - Planned nursing home admission after acute hospital stay - Current participation in another clinical trial, or plans of such participation in the next 12 months (corresponding to the study duration) - Inability to read and/or speak German to an extent necessary to understand instructions and participate in the study - Unwilling to forego any additional vitamin D supplementation (bolus or regular intake).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
STARK intervention
The STARK Intervention is a new care concept for hip fracture patients that enable hip fracture patient to return to their home directly after discharge from acute care. The STARK comprehensive autonomy health care package includes following services; Multidisciplinary collaboration of geriatricians, nurses and Spitex (ambulant nursing service at home) starting already during acute care Inspection of the environment at the patient's home Care and autonomy support Social life support Secondary prevention strategies: Home exercise program (3x/weeks) Protein enriched food preparation (20g whey protein/day) Support to take vitamin D supplementation (2000 IU/day) Recommendation and support to eat calcium rich foods Motivation to be physically active
Standard of Care
Standard of Care involves inpatient rehabilitation or home-based or inpatient transitional nursing care

Locations

Country Name City State
Switzerland Dept. of Geriatrics and Aging Research, University of Zurich / Geriatric Clinic University Hospital Zurich Zürich ZH

Sponsors (6)

Lead Sponsor Collaborator
University of Zurich City of Zurich, Switzerland, Ebnet Stiftung, Switzerland, Spitex Zürich, Switzerland, University Hospital, Zürich, University of Applied Sciences of Western Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Interaction of family carer with hip-fracture patient and health professionals The interaction will be assessed by semi-structured interviews with a family carer. 12 months
Primary Lower extremity function Lower extremity function will be measured by the Short Physical Performance Battery (SPPB) 12 months
Secondary Gait speed Gait speed will be obtained from the SPPB. 12 months
Secondary Gait speed Gait speed will be assessed by a 400 m walk test. 12 months
Secondary Grip strength Hand grip strength will be measured using a Martin Vigorimeter. 12 months
Secondary Repeated sit-to-stand Repeated chair stand test will be obtained from the SPPB. 12 months
Secondary Rate of falls Rate of falls will be assessed by a monthly phone call. 12 months
Secondary Health care utilization Health care utilization will be assessed using the health care utilization questionnaire. 12 months
Secondary Number of re-hospitalizations All hospitalizations will be documented as part of the safety documentation(SAE). 12 months
Secondary Number of nursing home admissions All nursing home admissions will be documented. 12 months
Secondary Adherence to preventive strategies Adherence will be documented by the Spitex staff. 3 months
Secondary Adherence to preventive strategies Adherence will be documented by an adherence questionnaire. 12 months
Secondary Quality of life Quality of life will be assessed by the RAND SF-36 questionnaire. 12 months
Secondary Quality of life Quality of life will be assessed by the EuroQol (EQ-5D-3L) questionnaire. 12 months
Secondary Cognitive function Cognitive function will be assessed by the MoCA. 12 months
Secondary Cognitive function Cognitive function will be assessed by the MMSE. 12 months
Secondary Appendicular muscle mass Appendicular muscle mass will be assessed by dual energy X-ray absorptiometry. 12 months
Secondary Bone mineral density Bone mineral density will be assessed by dual energy X-ray absorptiometry. 12 months
Secondary Activities of daily living Activities of daily living will be assessed by questionnaire (PROMIS-HAQ) 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Not yet recruiting NCT06431867 - Primary Care Management of Osteoporosis in Older Women
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Completed NCT01694784 - Understanding and Discouraging Overuse of Potentially Harmful Screening Tests N/A
Completed NCT02143674 - Muscle Strengthening Exercises and Global Stretching in Elderly N/A